p300-CBP coactivator/hypoxia-inducible factor-1alpha interaction inhibitors (University of Southern California/New York University)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namep300-CBP coactivator/hypoxia-inducible factor-1alpha interaction inhibitors (University of Southern California/New York University)
Drug Alias NameHBS-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor 1 alpha inhibitors
TargetsHypoxia-inducible factor 1 alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Southern California
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Southern CaliforniaNew York University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A